Abbott Laboratories has agreed to pull the weight loss drug Meridia (sibutramine) because clinical studies found rhe drug increased the risk of heart attacks and strokes. Approximately 8 million people worldwide take the drug, according to the FDA, ths includes about 100,000 Americans. “Meridia’s continued availability is not justified when...